Nanobiotix S.A.
NANO.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €50 | €75 | €39 | €84 |
| Short-Term Investments | €0 | €0 | €3 | €0 |
| Receivables | €9 | €9 | €3 | €4 |
| Inventory | €0 | €0 | €0 | €0 |
| Other Curr. Assets | €3 | €2 | €8 | €5 |
| Total Curr. Assets | €61 | €87 | €52 | €93 |
| Property Plant & Equip (Net) | €6 | €6 | €7 | €8 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €0 | €0 | €0 | €0 |
| Long-Term Investments | €0 | €0 | €0 | €0 |
| Tax Assets | €0 | €0 | €0 | -€0 |
| Other NC Assets | €0 | €0 | €0 | €0 |
| Total NC Assets | €6 | €7 | €7 | €9 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €67 | €94 | €60 | €102 |
| Liabilities | – | – | – | – |
| Payables | €4 | €7 | €4 | €5 |
| Short-Term Debt | €5 | €5 | €5 | €8 |
| Tax Payable | €7 | €0 | €0 | €0 |
| Deferred Revenue | €18 | €18 | €17 | €17 |
| Other Curr. Liab. | €24 | €19 | €12 | €7 |
| Total Curr. Liab. | €59 | €50 | €38 | €37 |
| LT Debt | €46 | €46 | €49 | €38 |
| Deferred Rev, NC | €0 | €0 | €0 | €0 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €0 |
| Other NC Liab. | €28 | €0 | €0 | €0 |
| Total NC Liab. | €74 | €46 | €49 | €38 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €4 | €5 | €6 | €7 |
| Total Liabilities | €133 | €96 | €87 | €75 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €56 | €46 |
| Common Stock | €1 | €1 | €1 | €1 |
| Retained Earnings | -€68 | -€40 | -€57 | -€47 |
| AOCI | -€312 | -€276 | -€284 | -€230 |
| Other Equity | €313 | €313 | €256 | €256 |
| Total Equity | -€66 | -€2 | -€27 | €27 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €67 | €94 | €60 | €102 |
| Net Debt | €1 | -€25 | €15 | -€38 |